Device Vte

Flowtriever Catheter, S

Payments companies reported to CMS as associated with Flowtriever Catheter, S. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$17Massociated payments (2023-2025)
26,329clinicians with associated payments
2companies reporting

By year

2023 $6.6M
2024 $6.7M
2025 $3.4M

Payments reported as associated with Flowtriever Catheter, S, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $3.8M
Vascular Surgery $2.6M
Interventional Cardiology $2.4M
Diagnostic Radiology $1.6M
Cardiovascular Disease $1.2M
Emergency Medicine $926K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Flowtriever Catheter, S

These are the largest totals companies reported as associated with Flowtriever Catheter, S. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Alexander Misono Newport Beach, CA Vascular & Interventional Radiology $678,866.39
Nicolas Mouawad West Branch, MI Vascular Surgery $373,108.79
Ripal Gandhi Miami, FL Vascular & Interventional Radiology $354,460.70
Peter Farrugia Colts Neck, NJ Cardiovascular Disease $348,250.00
Steven Abramowitz Washington, DC Vascular Surgery $295,270.69
Herman Kado Southfield, MI Cardiovascular Disease $273,686.23
Jason Berger Clearwater, FL Physician Assistant $254,930.67
Abdullah Shaikh Pittsburgh, PA Vascular & Interventional Radiology $226,782.37
Trevor Cummings Grand Rapids, MI Emergency Medicine $226,042.39
Raja Ramaswamy Indianapolis, IN Diagnostic Radiology $214,969.98

Prescribed Flowtriever Catheter, S?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.